GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lifecore Biomedical Inc (NAS:LFCR) » Definitions » E10

Lifecore Biomedical (Lifecore Biomedical) E10 : $-0.71 (As of May. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Lifecore Biomedical E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Lifecore Biomedical's adjusted earnings per share data for the three months ended in May. 2023 was $-1.190. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.71 for the trailing ten years ended in May. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Lifecore Biomedical was 52.90% per year. The lowest was -31.20% per year. And the median was 0.70% per year.

As of today (2024-04-28), Lifecore Biomedical's current stock price is $6.595. Lifecore Biomedical's E10 for the quarter that ended in May. 2023 was $-0.71. Lifecore Biomedical's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Lifecore Biomedical was 106.00. The lowest was 17.78. And the median was 28.84.


Lifecore Biomedical E10 Historical Data

The historical data trend for Lifecore Biomedical's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecore Biomedical E10 Chart

Lifecore Biomedical Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.26 0.14 -0.26 -0.71

Lifecore Biomedical Quarterly Data
Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.26 -0.32 -0.41 -0.57 -0.71

Competitive Comparison of Lifecore Biomedical's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifecore Biomedical's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lifecore Biomedical's Shiller PE Ratio falls into.



Lifecore Biomedical E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lifecore Biomedical's adjusted earnings per share data for the three months ended in May. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of May. 2023 (Change)*Current CPI (May. 2023)
=-1.19/128.3144*128.3144
=-1.190

Current CPI (May. 2023) = 128.3144.

Lifecore Biomedical Quarterly Data

per share eps CPI Adj_EPS
201308 0.180 98.675 0.234
201311 0.130 98.334 0.170
201402 0.240 99.057 0.311
201405 0.169 100.373 0.216
201408 0.090 100.352 0.115
201411 0.120 99.635 0.155
201502 0.140 99.032 0.181
201505 0.150 100.333 0.192
201508 0.110 100.548 0.140
201511 0.070 100.135 0.090
201602 -0.780 100.040 -1.000
201605 0.170 101.355 0.215
201608 0.120 101.617 0.152
201611 0.050 101.829 0.063
201702 0.130 102.779 0.162
201705 0.089 103.256 0.111
201708 0.080 103.587 0.099
201711 0.020 104.072 0.025
201802 0.570 105.052 0.696
201805 0.220 106.148 0.266
201808 0.010 106.383 0.012
201811 -0.020 106.338 -0.024
201902 0.030 106.649 0.036
201905 -0.010 108.048 -0.012
201908 -0.160 108.245 -0.190
201911 -0.230 108.519 -0.272
202002 -0.390 109.139 -0.459
202005 -0.520 108.175 -0.617
202008 -0.380 109.662 -0.445
202011 -0.450 109.793 -0.526
202102 -0.190 110.968 -0.220
202105 -0.100 113.576 -0.113
202108 -0.320 115.421 -0.356
202111 -1.300 117.269 -1.422
202202 -0.450 119.703 -0.482
202205 -1.240 123.323 -1.290
202208 -0.380 124.958 -0.390
202211 -0.420 125.607 -0.429
202302 -1.330 126.928 -1.345
202305 -1.190 128.314 -1.190

Add all the adjusted EPS together and divide 10 will get our e10.


Lifecore Biomedical  (NAS:LFCR) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Lifecore Biomedical was 106.00. The lowest was 17.78. And the median was 28.84.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Lifecore Biomedical E10 Related Terms

Thank you for viewing the detailed overview of Lifecore Biomedical's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifecore Biomedical (Lifecore Biomedical) Business Description

Traded in Other Exchanges
N/A
Address
3515 Lyman Boulevard, Chaska, MN, USA, 55318
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid.
Executives
Raymond T. White director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Holdings, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. Ii director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. I director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Asset Management, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Christopher S Kiper director 12121 WILSHIRE BLVD, SUITE 1240, LOS ANGELES CA 90025
Nathaniel Calloway director C/O ANEBULO PHARMACEUTICALS, INC., 1415 RANCH ROAD 620 SOUTH, SUITE 201, LAKEWAY TX 78734
Wynnefield Partners Small Cap Value Lp I 10 percent owner 450 SEVENTH AVENUE, SUITE 509, NEW YORK NY 10123
Raymond H Diradoorian director C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Joshua Schechter director C/O THE PANTRY, INC., 305 GREGSON DRIVE, CARY NC 27511
Patrick D Walsh director 14282 FRANKLIN AVE., TUSTIN CA 92780
John D Morberg officer: Chief Financial Officer C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Albert D. Bolles director CONAGRA FOODS, INC., ONE CONAGRA DRIVE, MS 1-330, OMAHA NE 68102
James G Hall officer: Executive Vice President 3515 LYMAN BLVD., CHASKA MN 55318